Related Experiment Videos
The BRAFT1796A transversion is a prevalent mutational event in human thyroid microcarcinoma
Ilya Sedliarou1, Vladimir Saenko, Dmitry Lantsov
1Department of Molecular Medicine, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences, 1-12-4 Sakamoto, Nagasaki 852-8523, Japan.
International Journal of Oncology
|November 18, 2004
Summary
BRAF mutations are common in thyroid papillary microcarcinoma (PMC), similar to papillary thyroid carcinoma (PTC). Follicular morphology was linked to no BRAF mutation, while mixed types showed increased BRAF mutation rates.
Area of Science:
- Oncology
- Genetics
- Endocrinology
Background:
- BRAF gene mutations, particularly in exon 15, are hallmarks of papillary thyroid carcinoma (PTC).
- Thyroid papillary microcarcinoma (PMC) is a subtype of PTC, and understanding its genetic drivers is crucial for diagnosis and treatment.
Purpose of the Study:
- To investigate the prevalence and significance of BRAF mutations in PMC.
- To explore the correlation between BRAF mutations and clinicopathological features of PMC.
Main Methods:
- Analysis of 46 PMC tumor samples from Russian and Japanese patients.
- Detection of BRAF mutations using molecular techniques (BRAFT1796A transversion).
- Statistical analysis correlating BRAF mutation status with patient demographics, tumor histology, and metastatic indices.
Main Results:
- BRAF mutations (BRAFT1796A) were detected in 28.2% of PMC cases, with similar rates across Russian and Japanese cohorts.
- No significant correlation was found between BRAF mutations and patient gender, age, or metastatic indices.
- Tumors with follicular morphology were associated with a lack of BRAF mutations (P=0.018), whereas mixed-type PMCs showed significantly higher BRAF mutational frequency (P=0.020).
Conclusions:
- The BRAFT1796A mutation is prevalent in PMC, suggesting shared genetic pathways with PTC.
- Tumor morphology plays a role in the genetic landscape of PMC, with follicular types diverging from mutation-associated patterns.
- These findings contribute to understanding the genetic spectrum of PMC and its relationship to PTC.